Lazada Urged to Remove Unregistered E-Cigarettes in Philippines

Mar.16.2023
Lazada Urged to Remove Unregistered E-Cigarettes in Philippines
Lazada urged to remove unregistered e-cigarettes from its platform, similar to Shopee, in compliance with Philippine e-cigarette regulations.

The Philippine E-Cigarette Industry Association (PECIA) and the Philippine Nicotine Consumers Union (NCUP) are urging Lazada to follow in the footsteps of Shopee and remove unregistered e-cigarette products in compliance with the country's Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), which will take effect on July 25, 2022.


The bill covers electronic cigarette products, e-cigarette juices, e-cigarette devices, heated tobacco products, HTP consumables and devices, and new tobacco products. With the IRR set to take effect on December 28, 2022, all prohibited items under RA 11900 will no longer be sold in online and offline retail markets.


Joey Dulay, the president of PECIA, has stated that Lazada, being one of the most popular online markets, should ensure consumer welfare and protect them from unregistered and substandard products that may cause harm.


The Ministry of Industry has stated unequivocally that Lazada is responsible for complying with e-cigarette-related legislation. Shopee is a platform similar in size to Lazada, and has taken down more than one million unregistered e-cigarette listings from its website. Lazada should also take this issue seriously.


In January of this year, NCUP wrote separate letters to Shopee and Lazada, commending Shopee for taking swift and decisive action against illegal electronic cigarette products, and strongly encouraging Lazada to follow the example set by its competitor.


These platforms have a huge influence on consumers. If they see it on websites, they will think it is safe. Lazada plays a crucial role in preventing the consumption of illegal products. There are now appropriate laws to regulate electronic cigarettes, but if the platform itself does not comply, the law cannot be enforced," said NCUP President Anton Israel in the letter.


On March 1st, representatives from electronic commerce platforms met with the Department of Trade and Industry (DTI) through the Consumer Protection Group (CPG) to address the issue of banned nicotine and non-nicotine vaping products being advertised and sold online despite ongoing monitoring and law enforcement efforts.


On March 1, 2022, the Department of Trade and Industry (DTI) of the Philippines held a meeting with representatives from e-commerce platforms through the Consumer Protection Group (CPG) to address the issue of prohibiting the sale of illegal e-cigarettes online.


One day after the dialogue, Shopee reported that it had removed over one million illegal listings of electronic cigarettes from its platform. It also pledged to strengthen its monitoring of illegal electronic cigarette products and commit to continued cooperation with the trade organization.


Under RA 11900, only electronic cigarette products, devices, and new tobacco products that are registered and certified by the Philippines' Bureau of Standards (BPS) and accompanied by appropriate health warnings can be sold to the public by June 2024.


PECIA is the largest trade organization for electronic cigarettes in the Philippines, with over 200 member shop owners, suppliers, and manufacturers, as well as more than 8,000 E-cigarette alliances, representing over one million smokeless product consumers in the Philippines.


NCUP is a non-profit national advocacy organization that believes the rights and interests of millions of smokers and electronic cigarette users in the Philippines need to be protected from the influence of untested, unregulated, and unregistered products.


Reference:


Lazada has been requested to take down illegal vaping products from its online marketplace.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08